OmniAb Corp (OABI) - שולי רווח נקי ממכירות

OmniAb, Inc. (OABI) attracts leading biologists and engineers through a tech-driven culture and RSUs. The sales margin on the GURU.Markets chart demonstrates profitability dynamics, where -108.10 reflects the metric's baseline. The company accelerates antibody discovery using transgenic animals, while a scalable royalty system across hundreds of partner programs minimizes the risk of isolated failures.
OmniAb Corp (OABI) - פילוחי מדדים ודוחות פיננסיים

Geopolitical fragmentation and trade barriers are limiting the global tests of OmniAb, Inc. (OABI), which directly reduces the inflow of licensing payments. The current value of -108.10 reflects the share of net profit in every dollar of revenue, allowing investors to assess operational efficiency and the business's margin of safety through the dynamics of the net profit margin.